HealingMaps Take: Oakton Primary Care integrates peptide therapy into primary care with both subcutaneous and oral BPC-157. Open 7 days a week.
Oakton Primary Care offers 1 specific peptide compound (BPC-157), placing it in the bottom half of the 10+ Virginia peptide clinics in our directory (the median clinic menu offers 2 compounds; the deepest offers 10). The clinic is physician-led (MD or DO); about half of Virginia peptide clinics in our directory are.
✓ Last verified: April 5, 2026 — Edited & verified by Angelica Bottaro for HealingMaps Editorial Staff
| Location | Oakton, VA |
| Address | 2915 Hunter Mill Rd, Suite 11, Oakton, VA 22124 |
| Phone | (703) 255-1190 |
| Website | oaktonprimarycarecenters.com |
| Treatments | BPC-157 (subcutaneous and oral) |
| Conditions Treated | Chronic pain, tissue repair, inflammation, healing |
| Clinical Lead | David Allingham, MD, MS |
Your prescribing provider, Dr. David Allingham, is verified in the federal CMS National Plan & Provider Enumeration System (NPPES) under NPI 1538229497, with a primary specialty of Personal Emergency Response Attendant and a primary practice address in Woodbridge, VA. CMS records show this NPI has been active since 2006. NPPES record verified 2026-05-08. Dr. David Allingham’s NPI tenure is shorter-tenured than most of the 4 Virginia peptide providers we’ve verified in NPPES (longest-tenured peer registered in 2006; cohort median 2006).
What this means for you: In the US, any actively state-licensed physician can legally prescribe compounded peptides — board certification in a specific specialty isn’t required for peptide prescriptions.
National peptide therapy pricing — based on 487 verified peptide clinics in our directory (April 2026 data). Adjust the calculator below to model your own protocol.
For more on how peptide therapy works, see our guide to peptide therapy.
Explore more vetted peptide therapy clinics near you in our nationwide directory.
Learn more about this treatment:
Looking for more BPC-157 providers? Browse our directory of BPC-157 and recovery peptide clinics — including options in Virginia across the United States.
Most Oakton Primary Care patients report the consult-to-first-injection window runs 1–3 weeks depending on lab turnaround and pharmacy fulfillment.
The questions below are pulled from the gaps in this specific listing — areas the clinic doesn’t publicly answer that you should clarify before booking. Each one is designed to get you a useful answer in 30 seconds or less.
Based on this listing, Oakton Primary Care names 1 specific peptide compound: BPC-157. The clinic may offer additional compounds not published on its public listing — confirm the full menu on a consult call.
Yes. Dr. David Allingham is registered in the federal CMS National Plan & Provider Enumeration System (NPPES) under NPI 1538229497, with a primary specialty of Personal Emergency Response Attendant and a primary practice address in Woodbridge, VA. The NPI has been active since 2006.
Oakton Primary Care doesn’t mention telehealth or virtual visits on its listing. Most peptide clinics require in-person evaluation for the initial consult; some offer virtual follow-ups once a patient is stable. If geography or travel matters to you, ask on the consult call whether they can prescribe and follow up virtually — and which states they’re licensed to do so in.
Among verified Virginia peptide clinics in the HealingMaps directory, Oakton Primary Care ranks in the bottom half of Virginia peptide clinics in the directory by compound depth. Compound depth is one signal among several — provider credentials, pharmacy sourcing transparency, and lab requirements also matter when comparing.
Oakton Primary Care is located in Oakton, Virginia. The full street address, phone number, and hours are listed in the data card above.
Themes drawn from HealingMaps editorial analysis of verified Virginia peptide clinics in our directory. Refreshed quarterly; percentages rounded to nearest 5%.
Across Virginia peptide clinics in our directory, BPC-157 appears in 60% of listings; Sermorelin in 35%; CJC-1295 in 15%; Ipamorelin in 15%. Compounds appearing in fewer than 20% of Virginia listings — including CJC-1295, Ipamorelin, Thymosin Beta-4 — are less commonly disclosed; patients seeking those should specifically ask whether the clinic prescribes them.
10% of Virginia clinics in our directory openly state whether they use a 503A or 503B compounding pharmacy. The rest leave the class unstated. The distinction matters for patients — 503A pharmacies fill prescriptions individually after your provider writes them (typically a few-day wait, in-state shipping), while 503B outsourcing facilities pre-batch under direct FDA inspection (often supporting same-visit fulfillment and direct-to-home shipping). Worth asking specifically before you book.
50% of verified Virginia clinics name an MD or DO as clinical lead (this listing’s clinical lead is Personal Emergency Response Attendant-trained). The remainder are NP/PA-led or don’t publicly name a specific prescribing clinician. Any state-licensed physician, NP, or PA can legitimately prescribe compounded peptides — but knowing your prescriber’s training and tenure helps you assess fit for your specific protocol.
The median Virginia clinic in our directory publishes 2 specific peptide compounds on its listing. The deepest disclosed menu names 10; 15% of listings name no specific compounds at all. A wide menu means more options at one clinic; a narrow menu can reflect specialization (e.g. weight-loss-only programs) or limited public disclosure (the clinic prescribes more than it advertises).
Pharmacy sourcing: This clinic doesn’t state its 503A or 503B compounding pharmacy partner. The class affects how your prescription is fulfilled — custom-compounded with in-state shipping (503A) versus pre-batched with broader shipping including direct-to-home delivery (503B) — so it’s worth asking before starting any compounded protocol.
Verified prescriber on the public record at Oakton Primary Care — NPI lookup confirms in CMS NPPES. The clinic’s menu publishes 1 compound (BPC-157 lead the list). The one piece missing publicly is pharmacy class disclosure (503A vs 503B); ask the clinic directly. See our full vetting rubric →
Leave a Reply